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1. Intr~uction 
Formylated peptides have been shown to be 
potent chemoattractants for leukocytes [1,2]. With 
the aid of an intrinsically labelled chemoattractant, 
f-Nle-Leu-[‘HIPhe (ML[3H]P) [3], a high affinity 
binding site (Kd 1.5 nM) was demonstrated for 
formylated peptides on rabbit neutrophils [4]. The 
no. binding sites/cell was estimated to be -10’. In 
[S], 0.7 X 10’ sites/cell were estimated. This putative 
receptor, in addition to binding a number of peptide 
agonists and antagonists, interacted with a partially 
purified chemotactic factor produced by Es~h~~hiu 
cc& 141. Others have demonstrated in human cells a 
similar eceptor for chemotactic peptides [6,7]. 
Here we present some characteristics of the 
chemoattractant binding site on the rabbit neutro- 
phil. In an approach similar to that used to character- 
ize other receptors uch as the opiate [8] and fl-adren- 
ergic [9] binding sites, we have investigated the 
correlation between binding and biological activity 
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for typical agonists and antagoni~s, the stereospeci- 
ficity of the receptor, the effects of pH and ionic 
en~ronment upon binding, and the chemical nature 
of the binding sites. 
2. Materials and methods 
Synthetic peptide attractants, both labelled and 
unlabelled, were obtained under NIDR contract 
DE-52477 and were composed of L-amino acids 
unless otherwise stated. f-L-Met-D-Leu-LPhe and 
the en~tiomers of Boc-Phe-mu-me-~u-~e 
were synthesized by J. B. and E. G.. The following 
chemicals were obtained from commercial sources: 
lectins; enzymes; gangliosides; dithiothreitol; tosyl-L- 
phenylalanyl chloromethane (TPCK); tosyl-L-lysyl 
chloromethane (TLCK); Cupferron, N-ethyl malei- 
mide; N-benzoyl tyrosine ethyl ester (BTEE); 
p-mercuribenzoate (pMB); and apdipyridyl. 
Rabbit peritoneal exudate cells were obtained as 
in [lo]. Particulate preparations for binding assays 
were prepared by disrupting frozen and thawed cells 
with the use of a Brinkman Polytron as in [4]. 
Chemotaxis was assayed in a modified Boyden 
1 
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chamber containing a 5 pm Millipore filter [lo]. 
Release of lysosomal enzymes in response to the 
presence of an attractant was determined as in [2]. 
The binding assay was performed as previously de- 
scribed, using f-Nle--LRu-[‘HIPhe (fNLL[3H]P) and 
whole cells or particulate fractions [4]. Gey’s bal- 
anced salt solution (pH 7.4) 2 ml, containing a sus- 
pension of 4.4 X lo6 cells or their particulate equiva- 
lent, 0.2 mol TPCK, 2.0 pmol(50 000 cpm) of 
fNLL[3H]P and, in some cases, a given concentra- 
tion of the competing peptide were incubated at 
4’C for 1 h. The cells were then rapidly filtered onto 
Whatman glass fiber filters (G F/B) under vacuum and 
washed rapidly with two 7 ml portions of cold 0.02 
M phosphate-buffered saline, pH 7.4 (PBS). After 
drying, the filters were counted by scintillation 
spectrometry. 
Cells were incubated for 30 min at 37°C with a 
given concentration of enzyme in Gey’s buffer to 
determine the effect of enzymatic pretreatment of 
cells upon their subsequent ability to bind fNLL[ ‘HIP. 
The cells were then washed free of enzyme, resus- 
pended in Gey’s buffer and assayed for binding of 
labelled attractant [4]. Cell viability after enzymatic 
treatment was assessed by determining trypan blue 
dye exclusion. 
3. Results 
jNLL[ 3H]P to whole cells 
3.1. Effect of proteoly tic inhibitors upon binding of 
We have demonstrated a protease activity in leuko- 
taxis, with specificity for aromatic ammo acid resi- 
dues [ 111. An enhanced binding of fNLL[ 3H] P to 
neutrophil receptors was found to occur in the pres- 
ence of the chymotryptic inhibitor TPCK [4]. We 
have examined the effect of chymotryptic and tryptic 
inhibitors and synthetic substrates for trypsin and 
chymotrypsin upon the specific binding* of 
fNLL[3H]P to determine whether proteolysis alters 
the interaction of ligand with receptor. Table 1 shows 
that 0.1 mM TPCK, but not TLCK stimulated the 
binding of a labelled substrate by 2-fold. Also TPCK, 
in contrast to TLCK, markedly inhibited chemotaxis. 
In [ 111 TPCK was more effective than TLCK in inhibit- 
* Specific binding is the difference between the total binding 
and the non-specific binding which occurred in the pres- 
ence of excess (1 PM) unlabelled fNLLP 
2 
Table 1 
Effects of protease inhibitors on chemotaxis and specific 
binding of fNLLi”H]P 
Inhibitor Percent inhibitionavb Percent specific 
of chemotaxis bindlngb 
None 0 100 
TPCK (0.1 mM) 100 191 
TLCK (0.1 mM) 12 109 
BTEE (0.1 mM) 99 93 
a Standard conditions as in section 2 were employed for both 
chemotaxis and binding 
b The values are means of triplicate measurements hat varied 
-4 0%; 3 experiments were done 
ing hydrolysis of a labelled attractant. BTEE, a chy- 
motryptic substrate, did not appreciably affect bind- 
ing but did depress chemotaxis. The tryptic substrate, 
tosyl-arginylchloromethane (TAME, not shown), at 
0.1 mM did not affect binding or chemotaxis. We 
have also found (not shown) that the presence of 
TPCK prevented a small degree of hydrolysis (<lo%) 
of labelled attractant by cells alone. TLCK did not 
inhibit this hydrolysis, which occurred at 4°C during 
the binding procedure. These results suggest hat a 
chymotryptic enzyme, perhaps closely associated 
with the binding site, may be required for chemotaxis 
and that its irreversible inhibition may contribute to 
enhanced binding of the attractant by preventing 
the latter’s hydrolysis. 
3.2. Correlation between binding of synthetic 
peptides and their effects upon neutrophil 
functions 
We had provided evidence for the physiological 
significance of this receptor in that we showed a 
correlation between the I.&-, of a peptide, that con- 
centration required to decrease by 50% the specific 
binding of the labelled attractant to the receptor, and 
its chemotactic E&c, that concentration which gives 
50% of the maximal chemotactic response [4]. 
Extending these observations (table 2) we show a 
correlation not only between the IDSo and chemotactic 
EDSo values for a number of typical peptides but 
also between inhibition of binding of fNLL[‘H]P 
and release of lysosomal enzymes. The values for 
enzyme release and inhibition of binding appear to 
be closer than those for chemotaxis and inhibition of 
binding. For example, for f-Met-Leu-Phe the IDS0 
is 3.3 X lo-” M, EDso for the enzyme release is 
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Table 2 
Comparison of the displacement of specific binding of MLL [ ‘HIP, chemotactic 
potencies and lysosomal enzyme releasing capacities of typical synthetic peptides 
Peptide Specific 
receptor 
ID,, Wa 
Cbemotactic 
activity 
ED,, (Wb 
Lysozyme releas- 
ing activity 
ED,, (MI 
f-Met-Leu-Phe 3.3 x lo-lo 7.0 x lo-” 2.4 x lo-l0 
f-Nle-Leu-PheC 3.4 x 1o-9 7.0 x lo-lo 1.5 x lo+ 
f-Met-Phe-Met 6.4 x lo-* 1.5 x 1o-9 2.6 x 1O-s 
f-CycloLeu-Leu-PheC 9.2 x 1o-6 4.6 x lo-’ 2.8 X 1O-6 
f-Cly-Leu-Phe 1.3 x 10-s 4.3 x 10-6 7.6 x lo+ 
a ID,, is the concentration of peptide required to displace 50% of the specific binding 
of the labelled attractant 
b ED,, is the concentration of peptide required to give 50% of the maximal chemotactic 
activity 
‘ED,, is the concentration of peptide required to give 50% of the maximal release of 
lysosomal enzyme 
fNLL[ ‘HIP was incubated with 5 concentrations of non-radioactive p ptides (section 2) 
The concentration required to displace 50% of specific binding was estimated from plots 
of % inhibition of specific binding peptide concentration. Values are means of triplicate 
values varying <l 0% 
2.4 X lo-” M, and the chemotactic E&, is 7.0 X 
10-l’ M. The results indicate that binding of a 
peptide is correlated closely with its ability to induce 
two biological responses in the neutrophil and that 
more binding is required to produce half-maximal 
enzyme release than is necessary for half-maximal 
chemotaxis. This correlation is observed for pep- 
tides that display a range of activities extending over 
5 orders of magnitude. 
3.3. Stereospecifcity of the receptor 
Since other well characterized receptors exhibited 
stereospecificity for their respective ligands [8,9] 
we determined whether this receptor responded 
stereospecifically. Using a number of stereoisomers 
(table 3) it was found that f-L-Met-L-Leu-L-Phe 
was both a better inhibitor of specific binding (IDso = 
3.8 X 10-r’ M) and a more active chemotactic agonist 
(EDso = 7.6 X 10-l’ M) than f-L-Met-D-Leu-L-Phe 
Table 3 
Effects of diastereoisomeric peptides upon neutrophil functions and binding of fNLL[ 3H]P to 
neutrophil receptor 
Peptide Specific 
bindin$9b 
ID,, W 
Chemotactic 
activity 
ED,, (MI 
Lysozyme 
releasing activ- 
irY ED,, (MI 
f-L-Met-L-Leu-L-Phe 3.8 x lo-“’ 7.6 X lo-” 3.2 x lo-” 
f-L-Met-D-Leu-L-Phe 8 x 10-s 6.0 x 10-s 4.0 x lo-* 
Boc-L-Phe-L-Leu-L-Phe-L-Leu-L-Plte 6.8 x 10-s 1.6 x lo-” 2.6 x 10-‘c 
Boc-D-Plte-D-Leu-D-Phe-D-Leu-D-Phe 3.7 x lo-’ 1.8 x 10-5c 3.6 x 10-‘c 
a These values were obtained from dose-inhibition plots of varying concentrations ofpeptides in the 
presence of the labelled &and 
b Values are means of triplicate measurements hat varied 4 0%; 3 experiments were done 
c These values are for the inhibition exerted by the antagonists (Boc compounds) upon chemotaxis 
and enzyme release in response to a maximally stimulating concentration of agonist (f-L-Met-L- 
Leu-L-Phe) 
Standard conditions as described in section 2, were employed for both chemotaxis, enzyme release 
and binding 
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wso = 8 X lo-’ M;E’se = 6.0 X lo-* M)_ Boc-L- 
Phe-L-Ieu-I_-Phe-L-Leu-L-Phe was a more effec- 
tive competitor (Ds, = 6.8 X 10-a M) than its 
enantiomer (Izzae = 3.7 X 10-’ M). However, they 
were equally effective chemotactic ~ta8onists of 
relatively low activity (10-s M). The poor antagonism 
of these inhibitors on chemotaxis compared to 
their effect upon binding could be the result of their 
degradation during the chemotactic assay period (2 h 
at 37’C). We have found (unpublished) that after 
such treatment in buffer alone both compounds lost 
potency in i~bit~ binding to the receptor. These 
results are in contrast o the more effective inhibi- 
tion by the ~tago~sts upon release of Iysosomal 
enzymes. These were observed after an incubation 
period of a only few minutes. 
cell purticuEate preparations 
Using a particulate cell preparation to control 
microenvironmental pHand levels of ions, we studied 
the effect of pH and different cations upon binding, 
Over a pH range from 6-9 optimal binding occurred 
from pH 6.5-7.0 (fig.1). An optimal chemotactic 
response was also observed within the same range 
(not shown). However, we could not observe appre- 
i t I I 
5 6 7 8 9 
PH 
Fig.1. Variation of specific binding with pH. Assay condi- 
tions fox specific binding were as in section 2, except that the 
buffer used in maintaining various pH values was Tris-ace- 
tate (0.1 M) and membrane preparations equivalent o 
2.2 X lo6 cells/ml were employed. The values are means of 
triplicate me~~ements which varied (10%. 
ciable changes in binding at pH 7.0 as a function of 
certain monovalent or divalent cation levels. Indeed 
the presence (not shown) of either Nd or K’ up to 
0.2 M or of each of 3 divalent cations (Ca2*, Mg2+ and 
Mn2*) up to 0.01 M did not alter binding by >30% 
from that observed with buffer alone. It appeared, 
therefore, that there were no specific requirements 
for common cations in binding ligand to receptor. 
Also, heavy metallic cations did not appear to be 
required for binding since a number of chelating 
agents had little effect (table 4). 
3 S . Effects of vatims treasons of whose cells and 
particulate prapara~~o~s upon specific binding 
We attempted to obtain ~fo~ation on the chem- 
ical nature of the putative receptpr in whole cells 
by subjecting them to a variety of pretreatments 
before they were assayed for their ability to bind 
ligand (table 4). Prior incubation with a variety of 
enzymes did not depress binding appreciably, In fact, 
some enzymes enhanced binding (papain by 49%; 
phospholipase A by 65%). This suggested that more 
receptors could be exposed by digesting away protein 
and small amounts of lipid constitutents of the cell 
membrane. In contrast, treatment with either 8 M 
urea or Triton X-100 el~ated binding of the ligand 
to whole cells and to particulate preparations. Results 
of using probes for roles of gangliosides and neura- 
mini& acid residues in binding were negative as were 
tests for specific sugars as part of the binding site 
utilizing a variety of lectins in both whole cells and 
particulate preparations. Cell viability appeared 
unimpaired by treatment with these enzymes and 
reagents, except for 8 M urea and Triton X-100. 
To identify factional groups (tabb 5) we used 
particulate preparations inorder to eliminate inter- 
nalization of receptor and attractant that might 
occur in whole cells. p-Mer~u~benzoate (pMB) pre- 
treatment at 10 PM caused >90% decrease in binding 
which was largely reversed by subsequent treatment 
with 0,l mM dit~othreitol. The latter reagent caused 
only a 25% decrease in binding. These results uggest 
the participation of free sulfhydryl groups in binding. 
The effect of pMB appears to be dependent on tem- 
perature since the simultaneous incubation of pMB 
and fNLL[3H)P with receptor-bearing fragments 
under assay conditions (0°C) did not affect binding. 
Amino-group reagents did not affect binding. From 
these results, which have been honeyed by 
Vitkauskas et al. (personal comm~cation~, it is not 
4 
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Table 4 
Effects of enzyme treatments and various reagents upon receptor-binding activity 
A. Enzymatic Percent change in B. Reagentsb$c Percent change in 
treatmenta specific binding added specific binding 
August 1980 
Protease 
(100 fig/ml) 
Papain 
t 100 fig/ml) 
Phospholipase A 
(250 lug/ml) 
Phospholipase C 
(250 Irglml) 
Phospholipase D 
(250 fig/ml) 
Neuraminidase 
(100 &ml) 
Glucosidase 
(100 Cr%ml) 
Galactosidase 
(100 fig/ml) 
CoBagenase 
(100 rg/ml) 
Elastase 
(200~dml) 
-2 
+49 
+65 
-1 
-8 
-8 
+10 
+16 
-20 
0 
Concanavalin A 
(20014iW) 
Galactose-binding 
protein (200 pg/ml) 
Soy bean agglutinin 
(200 pg/ml) 
Fucose-binding protein 
(200 ccg/ml) 
GangJioside mixture 
(1 mM) 
Triton X-l 00 
(1%) 
Urea (8 M) 
(0.1 mM) 
(0.1 M) 
EDTA 
(0.1 mM) 
crp-Dipyridyl 
(0.1 mM) 
Cupferron 
(0.1 mM) 
+6 
-8 
-4 
+13 
+9 
-93 
-90 
+4 
+25 
-10 
a Cells (2.2 X lo-e/ml) were preincubated for 30 min at 37’C with the enzyme. The cells were 
washed free of added enzyme and suspended in Gey’s solution and receptor binding assayed as in 
section 2 
b Values are means of triplicate assays that varied <lo%; 3 experiments were done 
c Reagents were present only during the assay procedures, except in the cases of Triton and urea, 
which were removed before assay of binding 
Table 5 
Effect of sulfhydryl reagents upon specific binding of fNLL[ 3H]P to particulate 
preparations of PMNs 
Pretreatmenta 
None 
p-Mercuribenzoate, lo-’ M 
p-Mercuribenzoate, 1O-$ M 
Percent of control bindingC 
100 
8 
followed by dithiothreitol, 1 Om4 M 
Dithiothreitol, 10m4 M 
p-Mercuribenzoate, 10-s M 
under assay conditionsb 
70 
75 
96 
a All pretreatments were done at 25’C for 40 min and the reagents removed 
before the binding assay 
b The reagent was present only during the binding assay (1 h at O’C) 
c Values are means of triplicate assays that varied <lo%; 4 experiments were 
done 
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possible to exclude any of the major classes (proteins, 
lipids, glycoconjugates) of membrane structural 
components as parts of the receptor. 
4. Discussion 
We have studied some properties of the putative 
receptor for formylated chemotactic peptides in rab- 
bit neutrophils. We have found that the binding of 
peptides to this receptor correlates well with the 
cell’s chemotactic responsiveness and lysosomal- 
enzyme releasing capacity. The IDso values for a 
number of compounds are very close to their respec- 
tive EDso values for typical peptides over a 5 orders 
of magnitude range of activities, substantiating a 
physiological role for the receptor. There is a stereo- 
specific preference that all amino acid residues pos- 
sess the L-configuration, This applies to the antago- 
nists as well as to the agonists. The antagonist with 
all L-residues has a binding affinity some 2 orders 
of magnitude l ss than the agonist with residues of 
the same configuration. However, the same antagonist 
binds as well as the diastereoisomeric agonist (f-L- 
Met-D-Leu-L-Phe). It is possible that most effective 
binding may require at least 3 sites of attachment to 
the receptor. The receptor appears to be a readily 
accessible surface component [5,12] which binds 
ligand with high affinity in a saturable, time-depen- 
dent process at low temperature. At higher temper- 
atures (unpublished) we could not obtain saturable 
binding nor complete release of pre-bound ligand, 
suggesting that some internalization of ligand- 
receptor complex had occurred as has been indicated 
for epidermal growth factor [12] and shown recently 
in human neutrophils [7,14,15]. 
These properties (high affinity, structural specific- 
ity, steric selectivity) result in a highly sensitive and 
discriminating cellular esponse, possibly involving 
hydrolysis of the peptide attractant by the cell [ 111. 
A role for hydrolysis might be to free the receptor 
from a molecule of attractant which had already 
delivered its signal, allowing the receptor to interact 
with a new molecule of attractant and sharpening the 
gradient in the vicinity of the cell [16]. There could, 
then, be two functionally distinct regions in the 
receptor, a ligand binding site and an hydrolytic 
enzyme. Support for this is the finding that the pro- 
teolytic inhibitor TPCK (but not TLCK), on one 
hand, inhibited chemotaxis and, on the other, 
6 
increased binding to the receptor. A bound chymo- 
trypsin-like sterase has been demonstrated on a 
neutrophil plasma membrane fraction also, which was 
the most enriched in chemotactic peptide binding 
sites of all the cellular subfractions [17]. However, 
the action of TPCK may be complex since it reacts 
with free sulfhydryl groups. 
Free sulfhydryl groups may be required for ligand- 
receptor binding since pMB reversibly inhibits this 
binding. This may result from an interaction ot 
directly at the binding site because pMB is not struc- 
turally related to chemotactic peptides. The sulfhy- 
dry1 requirement, also found in the glucocorticoid 
receptor [ 181, is evidence in favor of the receptor 
containing an essential protein component. 
The properties of the receptor appear to be consis- 
tent with the unique defensive role of the neutrophil 
as an inflammatory cell. It has high affinity for exceed- 
ingly small concentrations of the peptide attractant 
produced by E. coli [4] which is probably related to 
the formylated peptides used here. Therefore, the 
neutrophil can migrate along a gradient of attractant 
released by infecting bacteria. Chemotaxis n the pres- 
ence of relatively low levels of attractant may require 
only a small proportion of receptor occupancy since the 
EDso for chemotaxis less than the IDso for binding 
for a given peptide. Upon arriving at the site of infec- 
tion (high levels of bacterial attractant), the neutrophil 
phagocytizes the bacteria, behavior involving a secre- 
tion of lysosomal enzymes. This is consistent with the 
properties of the receptor since the EDso for lysosomal 
enzyme release is greater than that for chemotaxis. 
This may be an example of the same receptor modu- 
lating different cellular activities as a function of 
degree of receptor occupancy. Maximal binding occurs 
over the lower than physiological pH 6.5-7 .O. Unlike 
other receptors, its binding activity, but not its inter- 
nalization [7], appears both to be independent of
the presence of a number of common cations and 
resistant to the action of proteolytic enzymes. It binds 
ligand appreciably over a broad range of temperatures. 
Upon its arrival at a site of infection, these properties 
would clearly be an advantage tothe neutrophil, which 
must exercise its defensive function in a milieu of 
deranged homeostasis: low pH; variation in tempera- 
ture; ionic imbalance; and high levels of proteolytic 
activity. 
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